Quantcast
Published On: Sat, Nov 16th, 2013

Carbapenem-resistant infections on the rise in Europe: ECDC

Antibiotic resistance is showing a marked increase of carbapenem-resistant infections in the European Union (EU), according to a European Centre for Disease Prevention and Control (ECDC) press release Friday.

Acinetobacter baumannii Image/CDC/ Janice Haney Carr

Acinetobacter baumannii
Image/CDC/ Janice Haney Carr

According to the ECDC just before the 6th European Antibiotic Awareness Day on Nov. 18, the carbapenems are a major last-line class of antibiotics used to treat healthcare-associated infections. The proportion of Klebsiella pneumoniae bloodstream infections that is resistant to carbapenems has increased between 2009 and 2012, to above 5% in 5 countries, mostly in the south of Europe. A new serious concern is the emergence and spread of carbapenem-resistant Acinetobacter species, which is above 25% in 8 of 18 countries reporting data. This indicates even more seriously limited options for treatment of patients with Acinetobacter infections.

ECDC Director, Dr. Marc Sprenger said: “The data show that carbapenem-resistant infections are increasing in numbers and geographic spread across Europe. Since 2009, it has become increasingly common for hospitals to be faced with treating patients that have carbapenem-resistant infections, often meaning that old and toxic drugs are used. Given their very high proportion of carbapenem resistance, Acinetobacter infections already are serious problem for hospitals in many European countries.”

Concerning the EU country’s guidance and control of these serious infections, nearly half,  17 of the 38 participating countries still lack guidance for control of carbapenem-resistant infections, and only 2 countries reported having specific guidance to deal with carbapenem-resistant Acinetobacter infections.

Dr. Sprenger went on to say:”There is an urgent need for all European countries to have in place national guidance documents, so that hospitals faced with carbapenem-resistant infections can take action to control the spread and minimise the impact of outbreaks on patients. Together with infection control measures, improving antibiotic use is the most important action needed to greatly slow the very worrying development and spread of antibiotic-resistant bacteria.”

For more infectious disease news and information, visit and “like” the Infectious Disease News Facebook page

On the DISPATCH: Headlines  Local  Opinion

Subscribe to Weekly Newsletter

* indicates required
/ ( mm / dd ) [ALL INFO CONFIDENTIAL]

About the Author

- Writer, Co-Founder and Executive Editor of The Global Dispatch. Robert has been covering news in the areas of health, world news and politics for a variety of online news sources. He is also the Editor-in-Chief of the website, Outbreak News Today and hosts the podcast, Outbreak News Interviews on iTunes, Stitcher and Spotify Robert is politically Independent and a born again Christian Follow @bactiman63

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

like_us_on_facebook

 

The Global Dispatch Facebook page- click here

Movie News Facebook page - click here

Television News Facebook page - click here

Weird News Facebook page - click here 

DISPATCH RADIO

dispatch_radio

THE BRANDON JONES SHOW

brandon_jones_show-logo

Archives